Mylan Laboratories Inc

Headquarters location: 1500 Corporate Dr., Ste. 400 Canonsburg, PA 15317 Tel. 724-514-1800 Job offers, investor relations: www.mylan.com Email: investor_relations@mylan.com Stock:

Mylan Laboratories belongs to shareholder country     % source Barclays Plc 2.4 FMR Corp. (Fidelity Investments) 1.8 Lord Abbett & Co 2 State Street Corp. 2.3 TIAA-CREF 1.6 Vanguard Group Inc. 1.5	Brands name items photo compare the prices American Triumvirate Insurance Ethishop Bertek Pharmaceuticals Ethishop DocPharma (71,5%) Ethishop Matrix (71,5%) Ethishop Mylan Ethishop UDL Laboratories Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF MYLAN_LABORATORIES , group and subsidiaries [click on the images below or on help for more information] 1 Delinquency: 1 act(s) of financial or trade delinquency 1 Net profit: more than 1 billion(s) dollars/euros in cumulated net profit since 1998 288 Top management: earns 288 times the median income in the United States (32000 US$/year) Full profile >>>
Relevance: business & market share year business source 2007 Mylan sells 28,4% of the generic drugs bought in France. Les Echos 2006 Mylan is the second-largest generic drug maker in the U.S. Bloomberg 2006 Fifth-largest generic drug maker in the world. Les Echos World locations & Manufacturing country incentive : address & contact : production type source   Matrix (71,5%) : Production, Les Echos The map of tax haven, secret accounts and shell companies Mylan Laboratories is managed by year name photo position; compensation source 2006Coury, Robert J Chief Executive Officer; salary: 1.5 million US$; stock-options: 4.8 million US$; expenses: 2.94 million US$; AP 2003Borkowski, Edward Chief Financial Officer; 2003Coury, Robert J Chief Executive Officer; salary: 2.43 million US$; 2003DeBone, Louis J Chief Operating Officer; salary: 1.2 million US$; stock-options: 1.72 million US$; 2003Foster, Roger Vice-president; 2003Puskar, Milan Chairman; salary: 1.1 million US$; Highest paid executives in 2007

Made by year employees <> social impact : country source 2003 2450 2002 2450 Layoff plans and labour conditions in 2007 Financials year financial misdemeanor sales income buyback source 2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.     Canadian P. 2005   1.25 billion US$ 2004   1.37 0.33   billion US$ 2003   1.27 0.27   billion US$ 2002   1.1 0.26   billion US$ 2001   0.85 0.04   billion US$ 2000   0.79 0.15   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Banco internacional investimentos   No Tax Haven - Saturday 21 June 2008 at 13h02

Banco internacional investimentos   Another offshore bank? - Saturday 21 June 2008 at 13h00

Banco internacional investimentos   Sustainable Bank - Saturday 21 June 2008 at 12h54

Amerada hess   Reverend - Thursday 19 June 2008 at 08h17

Anshan benxi steel group   Sgt. - Thursday 19 June 2008 at 02h04

All comments